Dylan Essner explains how Epic, an electronic medical record, can be used by nurses and oncology providers who are treating patients with chimeric antigen receptor T-cell therapy.
Dylan Essner, an Epic Beacon Analyst at Washington University in St. Louis, explains how Epic, an electronic medical record (EMR), can be used by nurses and oncology providers who are treating patients with chimeric antigen receptor (CAR) T-cell therapy.
Essner describes the CAR T cell section of the Epic system and how the documentation tools for the cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), and immune-effector cell-associated encephalopathy (ICE) flowsheets. These 3 are all together in a flowsheet template for providers and nurses to document their patients.
ICANS and ICE have a formula built into the flowsheets, according to Essner, which allows the system to auto-populate the grade and score of the document. Medical professionals only need to input the different data points for each flowsheet; the grade for the patient will be calculated automatically. For patients with CRS, there is an informational chart to grade with. After the information has been added to a flowsheet, smart links will pull the data into the progress notes of the patient, which will make documentation easier for nurses and physicians.
<< View more resources and information regarding CAR T-cell therapy
Behind the FDA Approval of Liso-cel for Relapsed/Refractory CLL/SLL
March 15th 2024In an interview with Targeted Oncology, Tanya Siddiqi, MD, discussed the rationale behind the TRANSCEND CLL 004 study supporting the FDA approval of lisocabtagene maraleucel in chronic lymphocytic leukemia or small lymphocytic lymphoma.
Read More